コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 transferase designated SpyA (S. pyogenes ADP-ribosyltransferase).
2 1-diphosphate:decaprenyl-phosphate 5-phospho-ribosyltransferase.
3 no-associated viruses carrying a gene for C3 ribosyltransferase.
4 C-terminus (residues 232-453) encodes an ADP-ribosyltransferase.
5 e antibodies, suggesting that Sir2 is an ADP-ribosyltransferase.
6 ion of phospholipase D and cholera toxin ADP-ribosyltransferase.
7 locking ARF stimulation of cholera toxin ADP-ribosyltransferase.
8 otential for ExoS to function as an ecto-ADP-ribosyltransferase.
9 characterized as a diphthamide dependent ADP-ribosyltransferase.
10 bility of 14-3-3 to activate exoenzyme S ADP-ribosyltransferase.
11 xplore transition state analogue design in N-ribosyltransferases.
12 ress on their surfaces arginine-specific ADP ribosyltransferases.
13 y into hydrophobic subpockets in various ADP-ribosyltransferases.
14 nk between bacterial and vertebrate mono-ADP-ribosyltransferases.
15 guanidine, inhibitors of endogenous mono-ADP-ribosyltransferases.
16 P-ribosyltransferases than the bacterial ADP-ribosyltransferases.
17 ve been attributed to several vertebrate ADP-ribosyltransferases.
18 lyzed by a family of amino acid-specific ADP-ribosyltransferases.
19 anism of NAD binding and catalysis among ADP-ribosyltransferases.
20 ADP-ribose are conjugated to proteins by ADP-ribosyltransferases.
21 sted against a panel of homologous human ADP-ribosyltransferases.
22 e enzymatic activity of deacetylases and ADP ribosyltransferases.
23 oops, L1 and L4, not found in other mono-ADP-ribosyltransferases.
26 First, IENK cells express high levels of ADP-ribosyltransferase 2 (a marker of regulatory T cells in
27 usly expressed CD38 and T cell-expressed ADP-ribosyltransferase 2 (ART2) are ectoenzymes competing fo
28 We found that in the absence of CD38, ADP-ribosyltransferase 2 preferentially activates apoptotic
29 e to NAD-induced cell death activated by ADP ribosyltransferase-2 (ART2)-mediated ADP ribosylation of
32 ong these were genes encoding additional ADP-ribosyltransferases, a homolog of SrfC (a candidate effe
33 have two amino acid substitutions in the ADP-ribosyltransferase active center (E112K) and COOH-termin
34 lso carrying out ADP-ribosyl cyclase and ADP-ribosyltransferase activities, making SPN the only beta-
41 , we have used LFnDTA and its associated ADP-ribosyltransferase activity (DTA) to determine the requi
42 fector proteins include two enzymes with ADP-ribosyltransferase activity (ExoS and ExoT) and an acute
43 mutagenesis were quantified by measuring ADP-ribosyltransferase activity (i.e., auto-ADP-ribosylation
45 tein toxin that has diphthamide-specific ADP-ribosyltransferase activity against eukaryotic elongatio
46 hibition of ARF-stimulated cholera toxin ADP-ribosyltransferase activity and effects of ARF on mutant
47 Thus, redirection of TT is dependent on ADP-ribosyltransferase activity and GM1 binding and is assoc
48 l domain of ExoS possesses FAS-dependent ADP-ribosyltransferase activity and is cytotoxic to eukaryot
49 their ability to stimulate cholera toxin ADP-ribosyltransferase activity and later recognized as crit
50 their ability to stimulate cholera toxin ADP-ribosyltransferase activity and now recognized as critic
51 hat V. fischeri hvn null still possessed ADP-ribosyltransferase activity and that this activity is im
53 ion of ExoS was monitored by a sensitive ADP-ribosyltransferase activity assay, and specific activiti
55 omology, Exo53 has been shown to express ADP-ribosyltransferase activity at about 0.2% of the specifi
56 ExoT also affects PI3K signaling via its ADP-ribosyltransferase activity but does not act directly on
57 a E379D mutation inhibited expression of ADP-ribosyltransferase activity but had little effect on the
59 activity, and in J744-Eclone cells, ExoS ADP-ribosyltransferase activity caused a more severe inhibit
60 ein (GAP) activity, or ExoS defective in ADP-ribosyltransferase activity demonstrated that the virule
62 otein stimulated cholera-toxin-catalyzed ADP-ribosyltransferase activity in a reaction that was depen
63 estigate the structural requirements for ADP-ribosyltransferase activity in human PARP13 and two of i
64 uggest that the reported histone/protein ADP-ribosyltransferase activity is a low-efficiency side rea
65 ted B-oligomer subunit of PTX that lacks ADP ribosyltransferase activity nor the related cholera toxi
67 The ARF proteins stimulate the in vitro ADP-ribosyltransferase activity of cholera toxin and appear
68 purified by their ability to enhance the ADP-ribosyltransferase activity of cholera toxin and more re
69 tified by their ability to stimulate the ADP-ribosyltransferase activity of cholera toxin in vitro.
70 ons, the initial rate of FAS-independent ADP-ribosyltransferase activity of DeltaN222 was not linear
72 Antibodies to this epitope blocked the ADP-ribosyltransferase activity of ETA and appeared to inter
74 re, two aspects of the activation of the ADP-ribosyltransferase activity of ExoS by 14-3-3 proteins a
79 d NAD analogues and 32P-NAD to study the ADP-ribosyltransferase activity of several different sirtuin
80 r sirtuins, we propose that the reported ADP-ribosyltransferase activity of sirtuins is likely some i
81 e findings suggest that Sir2 contains an ADP-ribosyltransferase activity that is essential for its si
82 studies have localized the FAS-dependent ADP-ribosyltransferase activity to the carboxyl-terminus.
83 sis and analyzed both NAD(+) binding and ADP-ribosyltransferase activity using a fluorescence-based a
87 (LT), and LTK63 (an LT mutant devoid of ADP-ribosyltransferase activity) to elicit murine CD8(+) CTL
88 activation of Rab5 was dependent on ExoS ADP-ribosyltransferase activity, and in J744-Eclone cells, E
89 fter PTX and were dependent on intrinsic ADP-ribosyltransferase activity, as neither the cell binding
90 t inhibited by mutant LT with attenuated ADP-ribosyltransferase activity, CT B or LT B subunit, which
91 r ability to activate cholera toxin (CT) ADP-ribosyltransferase activity, have a critical role in ves
93 r mutant CT nor mutant LTh-1, which lack ADP-ribosyltransferase activity, redirected TT antigen into
108 concluded that ecto-NAD, as substrate of ADP ribosyltransferase, acts on naive, but not on activated
109 domain mutants of exoS revealed that the ADP-ribosyltransferase (ADP-r) activity of ExoS, but not the
113 ncludes both GTPase-activating (GAP) and ADP-ribosyltransferase (ADPRT) activities, and P. aeruginosa
115 (GAP) activity and the carboxy-terminal ADP-ribosyltransferase (ADPRT) activity of ExoS have been fo
117 olecular-weight G (LMWG) proteins and an ADP-ribosyltransferase (ADPRT) activity that targets LMWG pr
118 Significantly higher levels of ExoS ADP-ribosyltransferase (ADPRT) activity were detected in cul
119 s a 591-amino-acid virulence factor with ADP-ribosyltransferase (ADPRT) and vacuolating activities.
120 ards Rho family GTPases and a C-terminal ADP ribosyltransferase (ADPRT) domain with minimal activity
127 on as found in the A chain of CRM197, an ADP-ribosyltransferase (ADPrT)-deficient form of DTx, we hyp
129 at exhibits sequence similarity to known ADP-ribosyltransferases (ADPRTs) such as Bordetella pertussi
130 post-translational modification and the ADP-ribosyltransferases (also known as PARPs) responsible fo
131 vities from a single Sde polypeptide: an ADP-ribosyltransferase and a nucleotidase/phosphohydrolase.
132 ioinformatic strategy as a putative mono-ADP-ribosyltransferase and a possible virulence factor from
133 poly(ADP-ribose) polymerase (Tiparp), an ADP-ribosyltransferase and AHR repressor, increases sensitiv
135 a operon encodes dinitrogenase reductase ADP-ribosyltransferase and dinitrogenase reductase-activatin
138 dification of proteins with NAD:arginine ADP-ribosyltransferases and ADP-ribosylarginine hydrolases (
140 ribooxacarbenium ion transition states of N-ribosyltransferases and are tightly bound as the N4' cat
141 ross talk exists between bacterial toxin ADP-ribosyltransferases and host ADP-ribosylation cycles.
144 athologic process, PARP-1 and other poly(ADP-ribosyltransferases) are also localized within mitochond
145 Several proteins with NAD+:arginine ADP-ribosyltransferase (ART) activity are expressed in T cel
148 n is catalyzed by ART2.2, a GPI-anchored ADP-ribosyltransferase (ART) that is constitutively expresse
149 ithelial cells express arginine-specific ADP ribosyltransferase (ART)-1, a GPI-anchored ART that tran
150 sence of NAD-metabolizing enzymes (e.g., ADP-ribosyltransferase (ART)2) on the surface of immune cell
151 but not ADPR provides the substrate for ADP-ribosyltransferase (ART-2)-mediated attachment of ADP-ri
156 HvnB were presumptively designated mono-ADP-ribosyltransferases (ARTases), and it was hypothesized t
161 y mediated by a family of mammalian ecto-ADP-ribosyltransferases (ARTs) that covalently modify target
163 similarly ADP-ribosylated by endogenous ADP-ribosyltransferase, but only one arginine is modified at
165 icroinjection of a Clostridium botulinum ADP-ribosyltransferase (C3) and treatment with a ROCK specif
168 adenocarcinoma) cells with NAD:arginine ADP-ribosyltransferase cDNAs from Yac-1 murine lymphoma cell
170 s protein modification is often added by ADP-ribosyltransferases, commonly known as PARPs, but it can
171 mma ADP-ribosylation, indicates that rod ADP-ribosyltransferase contains two isozymes, and that these
173 indings reveal links between a mammalian ADP ribosyltransferase, cytokine-regulated metabolic activit
175 deacetylation reactions and can also process ribosyltransferase, demalonylase, and desuccinylase acti
176 eptococcus pyogenes produces a C3 family ADP-ribosyltransferase designated SpyA (S. pyogenes ADP-ribo
177 y the DRAT-DRAG (dinitrogenase reductase ADP-ribosyltransferase-dinitrogenase reductase-activating gl
178 dependent of the dinitrogenase reductase ADP-ribosyltransferase/dinitrogenase reductase activating gl
179 Furthermore, comparing with a bacterial ADP-ribosyltransferase diphtheria toxin, the observed rate c
180 yme S, which represent the FAS-dependent ADP-ribosyltransferase domain (termed deltaN222), and a poin
181 rm of ExoS rounded cells, indicating the ADP-ribosyltransferase domain alone is sufficient to elicit
182 aeruginosa, which comprises a C-terminal ADP ribosyltransferase domain and an N-terminal Rho GTPase-a
183 this study was to define the role of the ADP-ribosyltransferase domain in the modulation of eukaryoti
184 ese data indicate that expression of the ADP-ribosyltransferase domain of exoenzyme S is cytotoxic to
185 ngle amino acid mutation in the putative ADP-ribosyltransferase domain of SIRT1 inhibits the interact
186 us (residues 233-453) is a FAS-dependent ADP-ribosyltransferase domain that targets Ras and Ras-like
187 mapping has localized the FAS-dependent ADP-ribosyltransferase domain to the carboxyl-terminus of Ex
197 gulating enzymes dinitrogenase reductase ADP-ribosyltransferase (DRAT) and dinitrogenase reductase-ac
198 se reductase and dinitrogenase reductase ADP-ribosyltransferase (DRAT) from Rhodospirillum rubrum has
199 m a complex with dinitrogenase reductase ADP-ribosyltransferase (DRAT) from Rhodospirillum rubrum.
200 y inactivated by dinitrogenase reductase ADP-ribosyltransferase (DraT) in response to an increase in
201 lly regulated by dinitrogenase reductase ADP-ribosyltransferase (DRAT) via ADP-ribosylation of the ar
205 first structure of a DNA-targeting mono-ADP-ribosyltransferase enzyme; the structures of the apo-for
207 a nonphosphorylated protein ligand, the ADP-ribosyltransferase Exoenzyme S (ExoS) from Pseudomonas a
208 t to show that ADP-ribosylation of rho by C3 ribosyltransferase (exoenzyme) inhibits IL-2 production
209 uctural genes, exoS, encoding the 49-kDa ADP-ribosyltransferase (ExoS), and exoT, encoding the 53-kDa
212 that CerADPr possessed several conserved ADP-ribosyltransferase features, including an alpha-3 helix,
215 ene [yeast cytosine deaminase/uracil phospho-ribosyltransferase fusion (Fcy::Fur)] and the fusogenic
216 d initial characterization of a secreted ADP-ribosyltransferase, halovibrin (gene designation hvn), f
218 ecognized by specific antibodies against ADP-ribosyltransferase in the coronary arterial homogenates
219 s, we have discovered >20 novel putative ADP-ribosyltransferases, including several new potential tox
220 of P gamma arginine mutants, effects of ADP-ribosyltransferase inhibitors on the P gamma ADP-ribosyl
222 served NAD(+)-dependent deacetylases and ADP-ribosyltransferases involved in the regulation of cell d
224 hich is ADP-ribosylated by an endogenous ADP-ribosyltransferase, is required for the phosphorylation.
225 omonas aeruginosa exoenzyme S (ExoS), an ADP-ribosyltransferase, is translocated into eukaryotic cell
226 e bacterial enzyme S-adenosylmethionine:tRNA ribosyltransferase-isomerase (QueA) catalyzes the unprec
229 a 591-aa virulence factor with both mono-ADP ribosyltransferase (mART) and vacuolating activities kno
231 substrate for two enzyme families, mono-ADP-ribosyltransferases (mARTs) and poly(ADP-ribose) polymer
234 e activity but functions as an efficient ADP-ribosyltransferase on histones and bovine serum albumin.
237 afCAAX, this was sufficient to allow polyADP ribosyltransferase (PARP)-degradative apoptosis, but in
245 nserved NAD(+)-dependent deacetylases or ADP-ribosyltransferases, promote longevity in diverse organi
246 talytic domains of the nuclear-localized ADP-ribosyltransferase proteins (Adprt), two recently identi
247 yses of Tse6 show that it resembles mono-ADP-ribosyltransferase proteins, such as diphtheria toxin, w
249 pe III-secreted effector HopU1 is a mono-ADP-ribosyltransferase required for full virulence on Arabid
250 mbrane proteins on mouse T cells by ecto-ADP-ribosyltransferase(s) (ARTs) can down-regulate prolifera
253 r, inhibition of adenosine diphosphate (ADP) ribosyltransferase significantly decreased the response
256 t in the production of the streptococcal ADP-ribosyltransferase SpyA generates lesions of reduced siz
257 ed heterohexamers in which the catalytic ADP-ribosyltransferase subunit is activated when exposed to
258 3 cells is not significantly perturbed by C3 ribosyltransferase suggested that RhoA does not play a m
259 These data suggest that proteolysis of ADP-ribosyltransferase synthesized in transformed NMU cells
262 o acid homology with the vertebrate mono-ADP-ribosyltransferases than the bacterial ADP-ribosyltransf
264 EspJ as a unique adenosine diphosphate (ADP) ribosyltransferase that directly inhibits Src kinase by
265 eriments identify CerADPr as a cytotoxic ADP-ribosyltransferase that disrupts the host cytoskeleton.
266 enomic recombinant Sindbis virus C3), an ADP-ribosyltransferase that inactivates Rho, or dominant-neg
267 y of macrodomain-containing PARPs--is an ADP ribosyltransferase that interacts with Stat6, enhances i
268 ringae type III effector HopU1 is a mono-ADP-ribosyltransferase that is injected into plant cells by
269 nary toxin consisting of iota a (Ia), an ADP-ribosyltransferase that modifies actin, and iota b (Ib),
270 onas aeruginosa exoenzyme S (ExoS) is an ADP-ribosyltransferase that modifies low-molecular-weight GT
272 3-5, are NAD(+)-dependent deacylases and ADP-ribosyltransferases that are critical for stress respons
275 of protein deacetylases, deacylases, and ADP-ribosyltransferases that regulate life span, control the
276 ylases (HDACs), are protein deacetylases/ADP ribosyltransferases that target a wide range of cellular
277 educed liver injury, and animals lacking ADP-ribosyltransferase, the enzyme that uses NAD to attach A
279 nic Escherichia coli (ETEC) produces the ADP-ribosyltransferase toxin known as heat-labile enterotoxi
283 these toxins requires their activity as ADP-ribosyltransferases, transferring the ADP-ribose moiety
285 features, including an alpha-3 helix, an ADP-ribosyltransferase turn-turn loop, and a "Gln-XXX-Glu" m
286 insecticidal protein 2 (VIP2), an actin ADP-ribosyltransferase, unexpectedly implicates two adjacent
287 ADP-ribosylation is a PTM, in which ADP-ribosyltransferases use nicotinamide adenine dinucleotid
288 Mouse ART2, which is an NAD:arginine ADP-ribosyltransferase, was able to modify HNP-1, but to a l
289 mum PJ34, a well known inhibitor of poly-ADP-ribosyltransferases, was shown to be the most potent inh
290 ual target for modification by bacterial ADP-ribosyltransferases, we quantitatively compared the acti
291 (PDE), is ADP-ribosylated by endogenous ADP-ribosyltransferase when P gamma is free or complexed wit
292 data identify ExoS as a biglutamic acid ADP-ribosyltransferase, where E381 is the catalytic residue
295 enzyme S of Pseudomonas aeruginosa is an ADP-ribosyltransferase, which is secreted via a type III-dep
296 re NAD(+)-dependent protein deacetylases/ADP ribosyltransferases, which play decisive roles in chroma
297 cells expressing the cell surface enzyme ADP ribosyltransferase with nicotinamide adenine dinucleotid
298 Sirtuins are a family of deacylases and ADP-ribosyltransferases with clear links to regulation of ca
299 ibose) polymerase (PARP) family includes ADP-ribosyltransferases with diphtheria toxin homology (ARTD
300 generated in NMU cells by proteolysis of ADP-ribosyltransferase, with release of a carboxyl-terminal
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。